Suppr超能文献

非阻塞性冠状动脉粥样硬化患者血管内皮功能的影响因素:一项为期 1 年的观察性研究。

Influencing factors of vascular endothelial function in patients with non-obstructive coronary atherosclerosis: a 1-year observational study.

机构信息

Department of Nephrology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, 100053, China.

Department of Cardiology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, 100053, China.

出版信息

BMC Cardiovasc Disord. 2020 Jan 30;20(1):40. doi: 10.1186/s12872-020-01326-2.

Abstract

BACKGROUND

Endothelial dysfunction may play a key role in non-obstructive coronary artery atherosclerosis. Our study aimed to evaluate the vascular endothelial function and its influencing factors in patients with non-obstructive coronary artery atherosclerosis.

METHODS

A total of 131 consecutive patients with non-obstructive coronary artery atherosclerosis were enrolled. Flow-mediated dilatation (FMD) was measured at baseline and 1-year follow-up. Endothelial progenitor cells (EPCs) were counted by staining the fasting venous blood with antibodies against CD34 and vascular endothelial growth factor receptor 2.

RESULTS

Systolic blood pressure, pulse pressure and the levels of HbA1c in participants with baseline FMD < 6% (n = 65) were significantly higher than those with baseline FMD ≥ 6% (n = 66). Baseline FMD was negatively associated with EPC counts (r = - 0.199, P < 0.05) and systolic blood pressure (r = - 0.315, P < 0.01). The 1-year FMD was significantly increased compared to the baseline FMD [(9.31 ± 5.62) % vs (7.31 ± 5.26) %, P < 0.001]. Independent predictors of FMD improvement included elevated EPC counts (OR = 1.104, 95% CI: 1.047-1.165, P < 0.001) and decreased levels of serum creatinine (OR = 0.915, 95% CI: 0.843-0.993, P = 0.034).

CONCLUSIONS

Family history of premature cardiovascular diseases, hypertension, elevated systolic pressure, and HbA1c > 6.5% are independent risk factors for endothelial dysfunction in non-obstructive atherosclerotic patients. Elevated peripheral blood EPC counts and decreased levels of serum creatinine are independent predictors of endothelial function improvement.

摘要

背景

内皮功能障碍可能在非阻塞性冠状动脉粥样硬化中起关键作用。我们的研究旨在评估非阻塞性冠状动脉粥样硬化患者的血管内皮功能及其影响因素。

方法

共纳入 131 例连续的非阻塞性冠状动脉粥样硬化患者。在基线和 1 年随访时测量血流介导的扩张(FMD)。通过用针对 CD34 和血管内皮生长因子受体 2 的抗体对空腹静脉血进行染色来计数内皮祖细胞(EPC)。

结果

在基线 FMD<6%(n=65)的患者中,收缩压、脉压和 HbA1c 水平明显高于基线 FMD≥6%(n=66)的患者。基线 FMD 与 EPC 计数呈负相关(r=-0.199,P<0.05),与收缩压呈负相关(r=-0.315,P<0.01)。与基线 FMD 相比,1 年 FMD 显著增加[(9.31±5.62)%比(7.31±5.26)%,P<0.001]。FMD 改善的独立预测因素包括 EPC 计数升高(OR=1.104,95%CI:1.047-1.165,P<0.001)和血清肌酐水平降低(OR=0.915,95%CI:0.843-0.993,P=0.034)。

结论

早发心血管疾病家族史、高血压、收缩压升高和 HbA1c>6.5%是非阻塞性动脉粥样硬化患者内皮功能障碍的独立危险因素。外周血 EPC 计数升高和血清肌酐水平降低是内皮功能改善的独立预测因素。

相似文献

2
Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
Atherosclerosis. 2015 Feb;238(2):159-64. doi: 10.1016/j.atherosclerosis.2014.12.014. Epub 2014 Dec 11.
5
Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA).
Heart. 2014 Jun;100(11):862-6. doi: 10.1136/heartjnl-2013-304893. Epub 2014 Apr 8.
6
Impaired progenitor cell activity in age-related endothelial dysfunction.
J Am Coll Cardiol. 2005 May 3;45(9):1441-8. doi: 10.1016/j.jacc.2004.12.074.
10
Predictive value of Type D personality for impaired endothelial function in patients with coronary artery disease.
Int J Cardiol. 2018 May 15;259:205-210. doi: 10.1016/j.ijcard.2018.02.064. Epub 2018 Feb 20.

本文引用的文献

1
Endothelial Functions.
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):e108-e114. doi: 10.1161/ATVBAHA.117.309813.
3
The neutrophil-to-lymphocyte ratio as a marker of systemic endothelial dysfunction in asymptomatic subjects.
Nefrologia. 2016 Jul-Aug;36(4):397-403. doi: 10.1016/j.nefro.2015.10.018. Epub 2016 Feb 28.
4
Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.
Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H455-65. doi: 10.1152/ajpheart.00726.2015. Epub 2015 Dec 18.
5
6
The Role of Synthetic Extracellular Matrices in Endothelial Progenitor Cell Homing for Treatment of Vascular Disease.
Ann Biomed Eng. 2015 Oct;43(10):2301-13. doi: 10.1007/s10439-015-1400-x. Epub 2015 Jul 24.
7
Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease.
PLoS One. 2015 Jul 1;10(7):e0132047. doi: 10.1371/journal.pone.0132047. eCollection 2015.
8
Assessment of endothelial function. History, methodological aspects, and clinical perspectives.
Int Heart J. 2015;56(2):125-34. doi: 10.1536/ihj.14-385. Epub 2015 Feb 27.
9
Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches.
Pharmacol Ther. 2014 Dec;144(3):253-67. doi: 10.1016/j.pharmthera.2014.06.003. Epub 2014 Jun 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验